From Sunday, March 31st, a select group of patients will have the opportunity to purchase medical marijuana and its derivatives with prescriptions, eliminating the need for a special license. These groups include cancer patients undergoing chemotherapy or radiation, patients with inflammatory bowel diseases, multiple sclerosis, Parkinson’s syndrome, Tourette’s syndrome, HIV, epilepsy, dementia, terminally ill patients and those diagnosed with autism spectrum disorders. They will be able to buy drugs based on prescriptions written by doctors in hospitals or from health insurance funds. Private doctors will not be authorized to write prescriptions.
The aim of this reform is to simplify access to cannabinoid drugs and eliminate intermediaries who charge additional fees for expediting the licensing process for purchasing marijuana. Prescriptions will be electronic and specialist doctors will be able to issue them up to a year in advance. Additionally, medical marijuana will become more accessible for those who still require a license but no longer considered a “last resort” treatment option that can only be obtained after exhausting other methods.
However, the reform also addresses making medical marijuana more accessible for those who still need a license. It will no longer be classified as a “last resort” treatment method and will no longer require exhausting other forms of treatment before being considered for use. This move paves the way for easier access for more patients who could benefit from medical marijuana.
